1/15
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Epithelium type
Squamocolumnar
Viral risk factor
HPV 16 & 18
Incidence
Increasing; 9440 cases
More common in women
Race/Gender risk factor
White women and black men
Risk factors
HPV-16(universal among gay men)
Other cancers associated with HPV
HIV infection
Smoking
Anal sex
Lowered immunity
Prevention
HPV vaccination (boys and girls 11-12; females 13-26; males 13-21; MSM 26)
Condom use
Treatment of HIV
Smoking cessation
Diagnosis
Biopsy
CT of Chest/ABD/Pelvis or MRI of Pelvis
Anoscopy
Rigid proctosigmoidoscopy
Endoscopy
HIV test
Transrectal/Endorectal US
Gynecological exam for women
Staging
Most are clinical staging due to limit of surgery as primary treatment
Survival for Stage I
80%
Survival for Stage IV
35%
Management
local excision only for grade 1 well diff.
Radiation
Systemic
Radiation
Definitive therapy for Stages 1-3 w/ concurrent chemotherapy
Systemic Therapy - Stage 1-3
5-FU/mitomycin w/ radiation
Systemic Treatment for Stages IV
Cisplatin, 5-FU, FOLFOX, Carboplatin/Paclitaxel
Systemic Palliative Immunotherapy
Nivolumab/Pembrolizumab